ask="56.02"
ask_size="100"
average_daily_volume="1114300"
bid="37.50"
bid_size="100"
book_value="3.62"
change="+0.48"
change_from_200_day_moving_average="-2.85"
change_from_50_day_moving_average="0.85"
change_from_52_week_high="-12.07"
change_From_52_week_low="10.90"
change_in_percent="+1.13%"
close="43.08"
dividend_pay_date="N/A"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-1.63"
ebitda="-145.92M"
eps_estimate_current_year="-2.34"
eps_estimate_next_quarter="-0.63"
eps_estimate_next_year="-1.30"
ex_dividend_date="N/A"
float_shares="85906000"
high="43.84"
high_52_weeks="55.15"
last_trade_date="2/23/2017"
last_trade_price="43.08"
last_trade_size="130451"
last_trade_time="4:00pm"
low="42.17"
low_52_weeks="32.18"
market_capitalization="3.75B"
moving_average_200_day="45.93"
moving_average_50_day="42.23"
name="Neurocrine Biosciences
Inc."
notes="N/A"
one_year_target_price="67.67"
open="42.61"
pe_ratio="N/A"
peg_ratio="0.51"
percent_change_from_200_day_moving_average="-6.21%"
percent_change_from_50_day_moving_average="+2.01%"
percent_change_from_52_week_high="-21.89%"
percent_change_from_52_week_low="+33.87%"
previous_close="42.60"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="11.75"
price_per_sales="247.40"
revenue="15.00M"
shares_outstanding="87114000"
short_ratio="3.01"
stock_exchange="NMS"
symbol="NBIX"
volume="857461"
weeks_range_52="32.18 - 55.15"
